Insiders · Profile

O'Day Daniel Patrick

Chairman & CEO at Gilead Sciences. Filing since 30 May 2025. CIK 0001638643

Company
Date
Role
Action
Shares
Amount
Of holding
1 Oct 2026
Chairman & CEO
Sold on a plan
15,000
$2.22M
2.6%
1 Sep 2026
Chairman & CEO
Sold on a plan
15,000
$2.23M
2.5%
3 Aug 2026
Chairman & CEO
Sold on a plan
15,000
$1.95M
2.5%
1 Jul 2026
Chairman & CEO
Sold on a plan
15,000
$1.89M
2.4%
1 Jun 2026
Chairman & CEO
Sold on a plan
15,000
$1.97M
2.4%
28 Apr 2026
Chairman & CEO
Sold on a plan
10,000
$1.29M
1.6%
27 Mar 2026
Chairman & CEO
Sold on a plan
10,000
$1.37M
1.5%
27 Feb 2026
Chairman & CEO
Sold on a plan
10,000
$1.45M
1.5%
5 Feb 2026
Chairman & CEO
Sold on a plan
115,640
$17.35M
15.9%
28 Jan 2026
Chairman & CEO
Sold on a plan
10,000
$1.40M
1.8%
23 Jan 2026
Chairman & CEO
Sold on a plan
115,640
$15.61M
16.9%
29 Dec 2025
Chairman & CEO
Sold on a plan
10,000
$1.25M
1.7%
28 Nov 2025
Chairman & CEO
Sold on a plan
10,000
$1.27M
1.7%
28 Oct 2025
Chairman & CEO
Sold on a plan
10,000
$1.19M
1.7%
29 Sep 2025
Chairman & CEO
Sold on a plan
10,000
$1.12M
1.7%
28 Aug 2025
Chairman & CEO
Sold on a plan
10,000
$1.14M
1.7%
28 Jul 2025
Chairman & CEO
Sold on a plan
10,000
$1.14M
1.6%
30 Jun 2025
Chairman & CEO
Sold on a plan
10,000
$1.10M
1.6%
30 May 2025
Chairman & CEO
Sold on a plan
10,000
$1.10M
1.6%
19 decisions on file.